SG Americas Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

SG Americas Securities’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,443	Closed	-$193K	–	3586
2017 Q4	$193K	Sell	4,443 -604	-12%	-$25.7K	﹤0.01%	2463
2017 Q3	$215K	Buy	+5,047	New	+$214K	﹤0.01%	2527
2017 Q2	–	Sell	-13,073	Closed	-$547K	–	3576
2017 Q1	$547K	Sell	13,073 -21,745	-62%	-$886K	﹤0.01%	1790
2016 Q4	$1.36M	Buy	34,818 +24,240	+229%	+$986K	0.01%	1132
2016 Q3	$467K	Buy	+10,578	New	+$480K	﹤0.01%	1768
2016 Q2	–	Sell	-102,078	Closed	-$4.11M	–	3028
2016 Q1	$4.11M	Hold	102,078	–	–	0.03%	459
2015 Q4	$5.23M	Hold	102,078	–	–	0.04%	368
2015 Q3	$4.79M	Buy	102,078 +97,502	+2,131%	+$5.87M	0.03%	386
2015 Q2	$285K	Sell	4,576 -73,674	-94%	-$4.59M	﹤0.01%	1808
2015 Q1	$4.83M	Sell	78,250 -794	-1%	-$47.1K	0.03%	423
2014 Q4	$4.27M	Buy	79,044 +21,530	+37%	+$1.18M	0.02%	662
2014 Q3	$3.05M	Buy	57,514 +12,898	+29%	+$656K	0.02%	699
2014 Q2	$2.32M	Buy	44,616 +34,488	+341%	+$1.66M	0.01%	915
2014 Q1	$474K	Buy	+10,128	New	+$478K	﹤0.01%	1498
2013 Q4	–	Sell	-3,840	Closed	-$148K	–	3054
2013 Q3	$148K	Buy	+3,840	New	+$145K	﹤0.01%	2386

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

SG Americas Securities's XPH Position: Q1 2018 in Review

SG Americas Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 4,443 shares — an estimated $193K sold.

SG Americas Securities first reported a position in XPH in Q3 2013 and held it in 15 quarters. The position peaked at $5.23M in Q4 2015. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

SG Americas Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
SG Americas Securities sold 4,443 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $193K.
SG Americas Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2013 and held it in 15 quarters.
SG Americas Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $5.23M in Q4 2015.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.